Lipella Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lipella Pharmaceuticals generated cash of -$3,150,172, which is less than the previous year. Cash used in financing activities reached the amount of $1,336,601 last year. Net change in cash is therefore -$1,828,005.
Cash Flow
| 2019 | -39.11K | 0 | 25K |
|---|---|---|---|
| 2020 | -28.57K | 0 | 609.30K |
| 2021 | -989.27K | -300.54K | 2.09M |
| 2022 | -1.83M | 300.54K | 5.23M |
| 2023 | -3.15M | -14.43K | 1.33M |
LIPO Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 5.12M | 1.41M | 606.73K | 26.00K | 40.12K |
Operating activities | |||||
Net income | -4.61M | -2.59M | -1.86M | -61.65K | -61.84K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.68K | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 1.35M | 747.39K | 728.79K | 57.71K | 0 |
| Deferred income tax benefit | 1.35M | 747.39K | 728.79K | 57.71K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -113.65K | 69.03K | 14.85K | -43.77K |
Inventories | 0 | 113.65K | -69.03K | -14.85K | 0 |
Accounts payable | -246.34K | 337.45K | 22.36K | -24.80K | 33.44K |
Cash generated by operating activities | -3.15M | -1.83M | -989.27K | -28.57K | -39.11K |
Investing activities | |||||
Purchases Of Investments | 0 | 300.54M | -300.54K | 0 | 0 |
Investments In Property Plant And Equipment | -14.43K | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -14.43K | 300.54K | -300.54K | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 1.61M | 4.96M | 2.09M | 552.26K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -275K | 275K | 0 | -57.04K | 25K |
Cash used in financing activities | 1.33M | 5.23M | 2.09M | 609.30K | 25K |
Net Change In Cash | -1.82M | 3.70M | 807.09K | 580.73K | -14.11K |
Cash at end of period | 3.29M | 5.12M | 1.41M | 606.73K | 26.00K |
| Data source | Data source |